BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 321353)

  • 1. Use of fluorescent antibody in studies of immunity to cholera in infant mice.
    Guentzel MN; Field LH; Eubanks ER; Berry LJ
    Infect Immun; 1977 Feb; 15(2):539-48. PubMed ID: 321353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of cholera organisms in experimental Vibrio cholerae infections: proposed mechanisms of pathogenesis and antibacterial immunity.
    Schrank GD; Verwey WF
    Infect Immun; 1976 Jan; 13(1):195-203. PubMed ID: 1248870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of motility and flagellar structure in pathogenicity of Vibrio cholerae: analysis of motility mutants in three animal models.
    Richardson K
    Infect Immun; 1991 Aug; 59(8):2727-36. PubMed ID: 1855990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of motility in experimental cholera in adult rabbits.
    Yancey RJ; Willis DL; Berry LJ
    Infect Immun; 1978 Nov; 22(2):387-92. PubMed ID: 730361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Vibrio cholerae mutants with the intestinal mucosa of infant mice.
    Guentzel MN; Amerine D; Guerrero D; Gay TV
    Scan Electron Microsc; 1981; 4():115-24. PubMed ID: 7347415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flagella-induced immunity against experimental cholera in adult rabbits.
    Yancey RJ; Willis DL; Berry LJ
    Infect Immun; 1979 Jul; 25(1):220-8. PubMed ID: 478635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo adherence and colonization of Vibrio cholerae strains that differ in hemagglutinating activity and motility.
    Teppema JS; Guinée PA; Ibrahim AA; Pâques M; Ruitenberg EJ
    Infect Immun; 1987 Sep; 55(9):2093-102. PubMed ID: 3623694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vitro studies.
    Freter R; Allweiss B; O'Brien PC; Halstead SA; Macsai MS
    Infect Immun; 1981 Oct; 34(1):241-9. PubMed ID: 7298186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of growth of Vibrio cholerae in the intestine of immunized mice.
    Knop J; Bellamy JE
    Med Microbiol Immunol; 1976 Jun; 162(2):153-8. PubMed ID: 934024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: fitness and virulence of nonchemotactic Vibrio cholerae mutants in infant mice.
    Freter R; O'Brien PC
    Infect Immun; 1981 Oct; 34(1):222-33. PubMed ID: 7298184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motility as a virulence factor for Vibrio cholerae.
    Guentzel MN; Berry LJ
    Infect Immun; 1975 May; 11(5):890-7. PubMed ID: 1091563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies.
    Freter R; O'Brien PC; Macsai MS
    Infect Immun; 1981 Oct; 34(1):234-40. PubMed ID: 7298185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.
    Levinson KJ; De Jesus M; Mantis NJ
    Infect Immun; 2015 Apr; 83(4):1674-83. PubMed ID: 25667263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parameters affecting the association of vibrios with the intestinal surface in experimental cholera.
    Freter R
    Infect Immun; 1972 Aug; 6(2):134-41. PubMed ID: 4654645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial immunity to Vibrio cholerae in rats.
    Cooper GN; Narendranathan R
    J Med Microbiol; 1986 Sep; 22(2):133-41. PubMed ID: 3746875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: chemotactic responses of Vibrio cholerae and description of motile nonchemotactic mutants.
    Freter R; O'Brien PC
    Infect Immun; 1981 Oct; 34(1):215-21. PubMed ID: 7298183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RpoS controls the Vibrio cholerae mucosal escape response.
    Nielsen AT; Dolganov NA; Otto G; Miller MC; Wu CY; Schoolnik GK
    PLoS Pathog; 2006 Oct; 2(10):e109. PubMed ID: 17054394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence of wild-type and mutant strains of Vibrio cholerae to normal and immune intestinal tissue.
    Bhattacharjee JW; Srivastava BS
    Bull World Health Organ; 1979; 57(1):123-8. PubMed ID: 311709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virulence factors involved in the intraperitoneal infection of adult mice with Vibrio cholerae.
    Eubanks ER; Guentzel MN; Berry LJ
    Infect Immun; 1976 Feb; 13(2):457-63. PubMed ID: 1262061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes.
    Levinson KJ; Baranova DE; Mantis NJ
    Vaccine; 2016 Nov; 34(48):5833-5836. PubMed ID: 27773473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.